Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesis

International Journal of Drug Policy

Volumn 52, Issue , 2018, Pages 87-96

  Russell, Cayley ^a   Rueda, Sergio ^a,b   Room, Robin ^c,d   Tyndall, Mark ^e,f   Fischer, Benedikt ^a,b,g,h  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LA TROBE UNIVERSITY   (Australia)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g SIMON FRASER UNIVERSITY   (Canada)

^h FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cannabis; Health; Legalization; Policy; Routes of administration; Use methods

Indexed keywords

CANNABIS;

ACUTE DISEASE; ADVERSE OUTCOME; BRONCHITIS; CANNABIS ADDICTION; CANNABIS SMOKING; CANNABIS USE; COMBUSTION; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG SAFETY; HEALTH HAZARD; HUMAN; LUNG DISEASE; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SHORT SURVEY; SYSTEMATIC REVIEW; VAPORIZATION; CHEMISTRY; DRUG LEGISLATION; EPIDEMIOLOGY; PUBLIC HEALTH;

CANNABIS; HUMANS; LEGISLATION, DRUG; MARIJUANA SMOKING; MARIJUANA USE; PREVALENCE; PUBLIC HEALTH;

EID: 85038817970     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2017.11.008     Document Type: Short Survey

References (176)

1. Abrams, D.I., Vizoso, H.P., Shade, S.B., Jay, C., Kelly, M.E., Benowitz, N.L., Vaporization as a smokeless cannabis delivery system: A pilot study. Clinical Pharmacology and Therapeutics 82 (2007), 572–578.
2. Agrawal, A., Lynskey, M.T., Tobacco and cannabis co-occurrence: Does route of administration matter?. Drug and Alcohol Dependence 99 (2009), 240–247.
3. Agrawal, A., Budney, A.J., Lynskey, M.T., The co-occurring use and misuse of cannabis and tobacco: A review. Addiction (Abingdon England) 107 (2012), 1221–1233.
4. Appelboam, A., Oades, P.J., Coma due to cannabis toxicity in an infant. European Journal of Emergency Medicine 13 (2006), 177–179.
5. Azofeifa, A., Mattson, M.E., Schauer, G., McAfee, T., Grant, A., Lyerla, R., National estimates of marijuana use and related indicators − National survey on drug use and health, United States, 2002–2014. Morbidity and Mortality Weekly Report 65 (2016), 1–28.
6. Baggio, S., Deline, S., Studer, J., Mohler-Kuo, M., Daeppen, J.B., Gmel, G., Routes of administration of cannabis used for nonmedical purposes and associations with patterns of drug use. The Journal of Adolescent Health 54 (2014), 235–240.
7. Belanger, R.E., Akre, C., Kuntsche, E., Gmel, G., Suris, J.C., Adding tobacco to cannabis—Its frequency and likely implications. Nicotine & Tobacco Research 13 (2011), 746–750.
8. Bell, C., Slim, J., Flaten, H.K., Lindberg, G., Arek, W., Monte, A.A., Butane hash oil burns associated with marijuana liberalization in colorado. Journal of Medical Toxicology 11 (2015), 422–425.
9. Benjamin, D.M., Fossler, M.J., Edible cannabis products: It is time for FDA oversight. Journal of Clinical Pharmacology 56 (2016), 1045–1047.
10. Beshay, M., Kaiser, H., Niedhart, D., Reymond, M.A., Schmid, R.A., Emphysema and secondary pneumothorax in young adults smoking cannabis. European Journal of Cardio-Thoracic Surgery 32 (2007), 834–838.
11. Bloor, R.N., Wang, T.S., Spanel, P., Smith, D., Ammonia release from heated 'street’ cannabis leaf and its potential toxic effects on cannabis users. Addiction 103 (2008), 1671–1677.
12. Borodovsky, J.T., Crosier, B.S., Lee, D.C., Sargent, J.D., Budney, A.J., Smoking, vaping, eating: Is legalization impacting the way people use cannabis?. The International Journal on Drug Policy 36 (2016), 141–147.
13. Bouti, K., Rajae, B., Hicham, F., Harrak, L., Cannabis smoking and risk of lung cancer: A systematic review and meta-analysis. International Journal of Medicine and Surgery, 2014, 1.
14. Budney, A.J., Sargent, J.D., Lee, D.C., Confirmation of the trials and tribulations of vaping. Addiction (Abingdon, England) 110 (2015), 1710–1711.
15. Budney, A.J., Sargent, J.D., Lee, D.C., Vaping cannabis (marijuana): Parallel concerns to e-cigs?. Addiction (Abingdon, England) 110 (2015), 1699–1704.
16. Callaghan, R.C., Allebeck, P., Sidorchuk, A., Marijuana use and risk of lung cancer: A 40-year cohort study. Cancer Causes and Control 24 (2013), 1811–1820.
17. Cao, D., Srisuma, S., Bronstein, A.C., Hoyte, C.O., Characterization of edible marijuana product exposures reported to United States poison centers. Clinical Toxicology (Philadelphia Pa.) 54 (2016), 840–846.
18. Carstairs, S.D., Fujinaka, M.K., Keeney, G.E., Ly, B.T., Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine. The Journal of Emergency Medicine 41 (2011), e69–71.
19. Cavazos-Rehg, P.A., Sowles, S.J., Krauss, M.J., Agbonavbare, V., Grucza, R., Bierut, L., A content analysis of tweets about high-potency marijuana. Drug and Alcohol Dependence 166 (2016), 100–108.
20. Cavazos-Rehg, P.A., Zewdie, K., Krauss, M.J., Sowles, S.J., “No high like a brownie high” A content analysis of edible marijuana tweets. American Journal of Health Promotion, 2017 [0890117116686574].
21. Chabrol, H., Roura, C., Armitage, J., Bongs, a method of using cannabis linked to dependence. Canadian Journal of Psychiatry, 48, 2003, 709.
22. Cohn, A., Johnson, A., Ehlke, S., Villanti, A.C., Characterizing substance use and mental health profiles of cigar, blunt, and non-blunt marijuana users from the National Survey of Drug Use and Health. Drug and Alcohol Dependence 160 (2016), 105–111.
23. Colorado Department of Public Health and Environment, Monitoring health concerns related to marijuana in colorado: 2016. 2016, Colorado Department of Public Health and Environment, Denver, Colorado.
24. Cooper, Z.D., Haney, M., Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug and Alcohol Dependence 103 (2009), 107–113.
25. Cox, B., Can the research community respond adequately to the health risks of vaping?. Addiction (Abingdon, England) 110 (2015), 1708–1709.
26. Cranford, J.A., Bohnert, K.M., Perron, B.E., Bourque, C., Ilgen, M., Prevalence and correlates of Vaping as a route of cannabis administration in medical cannabis patients. Drug and Alcohol Dependence 169 (2016), 41–47.
27. Cuttler, C., Mischley, L.K., Sexton, M., Sex differences in cannabis use and effects: A cross-sectional survey of cannabis users. Cannabis and Cannabinoid Research 1 (2016), 166–175.
28. Daniulaityte, R., Nahhas, R.W., Wijeratne, S., Carlson, R.G., Lamy, F.R., Martins, S.S., et al. Time for dabs: Analyzing Twitter data on marijuana concentrates across the U.S. Drug and Alcohol Dependence 155 (2015), 307–311.
29. Degenhardt, L., Ferrari, A.J., Calabria, B., Hall, W.D., Norman, R.E., McGrath, J., et al. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: Results from the GBD 2010 study. Public Library of Science, 8, 2013, e76635.
30. Degenhardt, L., Whiteford, H.A., Ferrari, A.J., Baxter, A.J., Charlson, F.J., Hall, W., et al. Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. Lancet (London England) 382 (2013), 1564–1574.
31. Dolan, K., Clement, N., Rouen, D., Rees, V., Shearer, J., Wodak, A., Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?. Drug and Alcohol Review 23 (2004), 281–286.
32. Dunlap, E., Johnson, B.D., Benoit, E., Sifaneck, S., Sessions, cyphers, and parties: Settings for informal social controls of blunt smoking. Journal of Ethnicity in Substance Abuse 4 (2005), 43–79.
33. Earleywine, M., Barnwell, S.S., Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal, 4, 2007, 11.
34. Earleywine, M., Van Dam, N.T., Case studies in cannabis vaporization. Addiction Research and Theory 18 (2010), 243–249.
35. ElSohly, M.A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., Church, J.C., Changes in cannabis potency over the last 2 decades (1995–2014): Analysis of current data in the United States. Biological Psychiatry 79 (2016), 613–619.
36. Etter, J.F., Electronic cigarettes and cannabis: An exploratory study. European Addiction Research 21 (2015), 124–130.
37. Fairman, B.J., Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts. Drug and Alcohol Dependence 150 (2015), 77–84.
38. Favrat, B., Menetrey, A., Augsburger, M., Rothuizen, L.E., Appenzeller, M., Buclin, T., et al. Two cases of cannabis acute psychosis following the administration of oral cannabis. BMC Psychiatry, 5, 2005, 17.
39. Fiorelli, A., Accardo, M., Vicidomini, G., Messina, G., Laperuta, P., Santini, M., Does cannabis smoking predispose to lung bulla formation?. Asian Cardiovascular & Thoracic Annals 22 (2014), 65–71.
40. Fischer, B., Russell, C., Tyndall, M.W., Cannabis vaping and public health–some comments on relevance and implications. Addiction (Abingdon, England) 110 (2015), 1705–1706.
41. Fischer, B., Imtiaz, S., Rudzinski, K., Rehm, J., Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities. Journal of Public Health 38 (2016), 183–188.
42. Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., et al. Lower-risk cannabis use guidelines: A comprehensive update of evidence and recommendations. American Journal of Public Health 107:8 (2017), e1–e12.
43. Freeman, T.P., Morgan, C.J., Hindocha, C., Schafer, G., Das, R.K., Curran, H.V., Just say ‘know’: How do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints?. Addiction (Abingdon, England) 109 (2014), 1686–1694.
44. Friese, B., Slater, M.D., Annechino, R., Battle, R.S., Teen use of marijuana edibles: A focus group study of an emerging issue. The Journal of Primary Prevention 37 (2016), 303–309.
45. Gartner, C.E., Hall, W., Harm reduction policies for tobacco users. International Journal of Drug Policy 21 (2010), 129–130.
46. Gartner, C.E., Mull it over: Cannabis vaporizers and harm reduction. Addiction (Abingdon, England) 110 (2015), 1709–1710.
47. Gates, P., Jaffe, A., Copeland, J., Cannabis smoking and respiratory health: Consideration of the literature. Respirology 19 (2014), 655–662.
48. Geshtakovska, G., Stefkov, G., Routes of cannabis administration: A brief review. Macedonian Pharmaceutical Bulletin 62 (2016), 515–516.
49. Ghosh, T.S., Van Dyke, M., Maffey, A., Whitley, E., Erpelding, D., Wolk, L., Medical marijuana's public health lessons–implications for retail marijuana in Colorado. The New England Journal of Medicine 372 (2015), 991–993.
50. Gieringer, D., StLaurent, J., Goodrich, S., Cannabis vaporizer combines efficient delivery of THC with effective suppression of pyrolitic compounds. Journal of Cannabis Therapeutics 4 (2004), 7–27.
51. Gieringer, D., Cannabis vaporization: A promising strategy for smoke harm reduction. Journal of Cannabis Therapeutics 1 (2001), 153–170.
52. Gill, A., Bong lung: Regular smokers of cannabis show relatively distinctive histologic changes that predispose to pneumothorax. American Journal of Surgical Pathology 29 (2005), 980–982.
53. Giroud, C., de Cesare, M., Berthet, A., Varlet, V., Concha-Lozano, N., Favrat, B., E-Cigarettes: A review of new trends in cannabis use. International Journal of Environmental Research and Public Health 12 (2015), 9988–10008.
54. Golub, A., Johnson, B.D., Dunlap, E., The growth in marijuana use among American youths during the 1990s and the extent of blunt smoking. Journal of Ethnicity in Substance Abuse 4 (2005), 1–21.
55. Gossop, M., Griffiths, P., Powis, B., Strang, J., Cocaine: Patterns of use, route of administration, and severity of dependence. The British Journal of Psychiatry 164 (1994), 660–664.
56. Gowing, L.R., White, J., Respiratory harms of smoked cannabis: Research monograph no.8. 2000, Drug and Alcohol Services Council of South Australia, Adelaide, AU.
57. Grotenhermen, F., Harm reduction associated with inhalation and oral administration of cannabis and THC. Journal of Cannabis Therapeutics 1 (2001), 133–152.
58. Grotenhermen, F., Cannabinoids for therapeutic use: Designing systems to increase efficacy and reliability. American Journal of Drug Delivery 2 (2004), 229–240.
59. Hakkarainen, P., Vaporizing the pot world–easy, healthy, and cool. Drugs and Alcohol Today 16 (2016), 185–193.
60. Hall, W., Degenhardt, L., Adverse health effects of non-medical cannabis use. The Lancet 374 (2009), 1383–1391.
61. Hall, W., Degenhardt, L., High potency cannabis: A risk factor for dependence, poor psychosocial outcomes, and psychosis. BMJ (Clinical Research Ed.), 2015, 350.
62. Hancock-Allen, J.B., Barker, L., VanDyke, M., Holmes, D.B., Notes from the field: Death following ingestion of an edible marijuana Product–Colorado: March 2014. MMWR Morbidity and Mortality Weekly Report 64 (2015), 771–772.
63. Hancox, R.J., Shin, H.H., Gray, A.R., Poulton, R., Sears, M.R., Effects of quitting cannabis on respiratory symptoms. The European Respiratory Journal 46 (2015), 80–87.
64. Hashibe, M., Straif, K., Tashkin, D.P., Morgenstern, H., Greenland, S., Zhang, Z.F., Epidemiologic review of marijuana use and cancer risk: A systematic review. Alcohol 35 (2005), 265–275.
65. Hashibe, M., Morgenstern, H., Cui, Y., Tashkin, D.P., Zhang, Z.F., Cozen, W., et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: Results of a population-based case-control study. Cancer Epidemiology Biomarkers & Prevention 15 (2006), 1829–1834.
66. Hazekamp, A., Ruhaak, R., Zuurman, L., van, G.J., Verpoorte, R., Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. Journal of Pharmaceutical Sciences 95 (2006), 1308–1317.
67. Hazekamp, A., Ware, M.A., Muller-Vahl, K.R., Abrams, D., Grotenhermen, F., The medicinal use of cannabis and cannabinoids-an international cross-sectional survey on administration forms. Journal of Psychoactive Drugs 45 (2013), 199–210.
68. Hazouard, E., Koninck, J.C., Attucci, S., Fauchier-Rolland, F., Brunereau, L., Diot, P., Pneumorachis and pneumomediastinum caused by repeated Muller's maneuvers: Complications of marijuana smoking. Annals of Emergency Medicine 38 (2001), 694–697.
69. Health Canada, Canadian alcohol and drug use monitoring survey (CADUMS): summary of results for 2012. 2014, Health Canada, Ottawa, ON.
70. Hii, S.W., Tam, J.D., Thompson, B.R., Naughton, M.T., Bullous lung disease due to marijuana. Respirology (Carlton, Vic.) 13 (2008), 122–127.
71. Hindocha, C., Freeman, T.P., Ferris, J.A., Lynskey, M.T., Winstock, A.R., No smoke without tobacco: A global overview of cannabis and tobacco routes of administration and their association with intention to quit. Frontiers in Psychiatry, 7, 2016, 104.
72. Hindocha, C., Freeman, T.P., Winstock, A.R., Lynskey, M.T., Vaping cannabis (marijuana) has the potential to reduce tobacco smoking in cannabis users. Addiction (Abingdon, England), 111, 2016, 375.
73. Hudak, M., Severn, D., Nordstrom, K., Edible cannabis-induced psychosis: Intoxication and beyond. The American Journal of Psychiatry 172 (2015), 911–912.
74. Imtiaz, S., Shield, K.D., Roerecke, M., Cheng, J., Popova, S., Kurdyak, P., et al. The burden of disease attributable to cannabis use in Canada in 2012. Addiction 111 (2016), 653–662.
75. Jensen, G., Bertelotti, R., Greenhalgh, D., Palmieri, T., Maguina, P., Honey oil burns: A growing problem. Journal of Burn Care & Research 36 (2015), e34–37.
76. Johnson, R.M., Brooks-Russell, A., Ma, M., Fairman, B.J., Tolliver, R.L. Jr., Levinson, A.H., Usual modes of marijuana consumption among high school students in Colorado. Journal of Studies on Alcohol and Drugs 77 (2016), 580–588.
77. Jones, C.B., Hill, M.L., Pardini, D.A., Meier, M.H., Prevalence and correlates of vaping cannabis in a sample of young adults. Psychology of Addictive Behaviors, 30, 2016, 915.
78. Keller, C.J., Chen, E.C., Brodsky, K., Yoon, J.H., A case of butane hash oil (marijuana wax)-induced psychosis. Substance Abuse 37 (2016), 384–386.
79. Kelly, B.C., Bongs and blunts: Notes from a suburban marijuana subculture. Journal of Ethnicity in Substance Abuse 4 (2005), 81–97.
80. Kempker, J.A., Honig, E.G., Martin, G.S., The effects of marijuana exposure on expiratory airflow: A study of adults who participated in the U.S. National Health and Nutrition Examination Study. Annals of the American Thoracic Society 12 (2015), 135–141.
81. Kilmer, B., Caulkins, J.P., Midgette, G., Dahlkemper, L., MacCoun, R.J., Liccardo, P.R., Before the grand opening: Measuring Washington State's marijuana market in the last year before legalized commercial sales. 2013, Rand Corporation, Santa Monica, CA.
82. King, B.A., Dube, S.R., Tynan, M.A., Current tobacco use among adults in the United States: Findings from the National Adult Tobacco Survey. American Journal of Public Health 102 (2012), e93–e100.
83. Koopman Gonzalez, S.J., Cofie, L.E., Trapl, E.S., I just use it for weed: The modification of little cigars and cigarillos by young adult African American male users. Journal of Ethnicity in Substance Abuse, 2015, 1–14.
84. Krauss, M.J., Sowles, S.J., Mylvaganam, S., Zewdie, K., Bierut, L.J., Cavazos-Rehg, P.A., Displays of dabbing marijuana extracts on YouTube. Drug and Alcohol Dependence 155 (2015), 45–51.
85. Krauss, M.J., Sowles, S.J., Stelzer-Monahan, H.E., Bierut, T., Cavazos-Rehg, P.A., It takes longer: But when it hits you it hits you!: Videos about marijuana edibles on YouTube. Substance Use and Misuse 52 (2017), 709–716.
86. Lamy, F.R., Daniulaityte, R., Sheth, A., Nahhas, R.W., Martins, S.S., Boyer, E.W., et al. Those edibles hit hard: Exploration of Twitter data on cannabis edibles in the U.S. Drug and Alcohol Dependence 164 (2016), 64–70.
87. Lankenau, S.E., Fedorova, E.V., Reed, M., Schrager, S.M., Iverson, E., Wong, C.F., Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users. Drug and Alcohol Dependence 170 (2017), 181–188.
88. Lanz, C., Mattsson, J., Soydaner, U., Brenneisen, R., Medicinal cannabis: In vitro validation of vaporizers for the smoke-free inhalation of cannabis. Public Library Of Science, 11, 2016, e0147286.
89. Lee, M.H., Hancox, R.J., Effects of smoking cannabis on lung function. Expert Review of Respiratory Medicine 5 (2011), 537–547.
90. Lee, J.P., Battle, R.S., Lipton, R., Soller, B., 'smoking’: Use of cigarettes, cigars and blunts among Southeast Asian American youth and young adults. Health Education Research 25 (2010), 83–96.
91. Lee, D.C., Crosier, B.S., Borodovsky, J.T., Sargent, J.D., Budney, A.J., Online survey characterizing vaporizer use among cannabis users. Drug and Alcohol Dependence 159 (2016), 227–233.
92. Loflin, M., Earleywine, M., A new method of cannabis ingestion: The dangers of dabs?. Addictive Behaviors 39 (2014), 1430–1433.
93. Loflin, M., Earleywine, M., No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk. Canadian Journal of Respiratory Therapy 51 (2015), 7–9.
94. MacCoun, R.J., Mello, M.M., Half-baked–the retail promotion of marijuana edibles. The New England Journal of Medicine 372 (2015), 989–991.
95. Macleod, J., Robertson, R., Copeland, L., McKenzie, J., Elton, R., Reid, P., Cannabis, tobacco smoking, and lung function: A cross-sectional observational study in a general practice population. The British Journal of General Practice 65 (2015), e89–95.
96. Malouff, J.M., Rooke, S.E., Copeland, J., Experiences of marijuana-vaporizer users. Substance Abuse 35 (2014), 127–128.
97. Mammen, G., Rehm, J., Rueda, S., Vaporizing cannabis through e-cigarettes: Prevalence and socio-demographic correlates among Ontario high school students. Canadian Journal of Public Health 107 (2016), e337–e338.
98. Mariani, J.J., Brooks, D., Haney, M., Levin, F.R., Quantification and comparison of marijuana smoking practices: Blunts, joints and pipes. Drug and Alcohol Dependence 113 (2011), 249–251.
99. Martinasek, M.P., McGrogan, J.B., Maysonet, A., A systematic review of the respiratory effects of inhalational marijuana. Respiratory Care 61 (2016), 1543–1551.
100. McDonald, E.A., Popova, L., Ling, P.M., Traversing the triangulum: the intersection of tobacco, legalized marijuana and electronic vaporisers in Denver, Colorado. Tobacco Control 25 (2016), i96–i102.
101. McMahon, M.J., Bhatt, N.A., Stahlmann, C.G., Philip, A.I., Severe pneumonitis after inhalation of butane hash oil. Annals of the American Thoracic Society 13 (2016), 991–992.
102. Mehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A.S., et al. Potency trends of Delta9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. Journal of Forensic Sciences 55 (2010), 1209–1217.
103. Mehra, R., Moore, B.A., Crothers, K., Tetrault, J., Fiellin, D.A., The association between marijuana smoking and lung cancer: A systematic review. Archives of Internal Medicine 166 (2006), 1359–1367.
104. Meier, E., Hatsukami, D.K., A review of the additive health risk of cannabis and tobacco co-use. Drug and Alcohol Dependence 166 (2016), 6–12.
105. Miller, B.L., Stogner, J.M., Miller, J.M., Exploring butane hash oil use: A research note. Journal of Psychoactive Drugs 48 (2016), 44–49.
106. Monte, A.A., Zane, R.D., Heard, K.J., The implications of marijuana legalization in Colorado. Journal of the American Medical Association 313 (2015), 241–242.
107. Montgomery, L., Bagot, K., Let's be blunt: Consumption methods matter among black marijuana smokers. Journal of Studies on Alcohol and Drugs 77 (2016), 451–456.
108. Montgomery, L., Oluwoye, O., The truth about marijuana is all rolled up in a blunt: Prevalence and predictors of blunt use among young African–American adults. Journal of Substance Use 21 (2016), 374–380.
109. Montgomery, L., Marijuana and tobacco use and co-use among African Americans: Results from the 2013 National Survey on Drug Use and Health. Addictive Behaviors 51 (2015), 18–23.
110. Moolchan, E.T., Zimmerman, D., Sehnert, S.S., Zimmerman, D., Huestis, M.A., Epstein, D.H., Recent marijuana blunt smoking impacts carbon monoxide as a measure of adolescent tobacco abstinence. Substance Use and Misuse 40 (2005), 231–240.
111. Morean, M.E., Kong, G., Camenga, D.R., Cavallo, D.A., Krishnan-Sarin, S., High school students’ use of electronic cigarettes to vaporize cannabis. Pediatrics 136 (2015), 611–616.
112. Munckhof, W.J., Konstantinos, A., Wamsley, M., Mortlock, M., Gilpin, C., A cluster of tuberculosis associated with use of a marijuana water pipe. The International Journal of Tuberculosis and Lung Disease 7 (2003), 860–865.
113. Murphy, F., Sales, P., Murphy, S., Averill, S., Lau, N., Sato, S.-O., Baby boomers and cannabis delivery systems. Journal of Drug Issues 45 (2015), 293–313.
114. National Academies of Sciences, Engineering, & Medicine, The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. 2017, The National Academies Press, Washington, DC.
115. Noack, R., Hofler, M., Lueken, U., Cannabis use patterns and their association with DSM-IV cannabis dependence and gender. European Addiction Research 17 (2011), 321–328.
116. Office of National Drug Control Policy (ONDCP), New report finds highest levels of THC in U.S. marijuana to date., 2009, Office of National Drug Control Policy (ONDCP), Washington, D.C.
117. Onders, B., Casavant, M.J., Spiller, H.A., Chounthirath, T., Smith, G.A., Marijuana exposure among children younger than six years in the United States. Clinical Pediatrics 55 (2016), 428–436.
118. Pacula, R.L., Jacobson, M., Maksabedian, E.J., In the weeds: A baseline view of cannabis use among legalizing states and their neighbours. Addiction (Abingdon England) 111 (2016), 973–980.
119. Pardo, B., Cannabis policy reforms in the Americas: A comparative analysis of Colorado, Washington, and Uruguay. The International Journal on Drug Policy 25 (2014), 727–735.
120. Peace, M.R., Butler, K.E., Wolf, C.E., Poklis, J.L., Poklis, A., Evaluation of two commercially available cannabidiol formulations for use in electronic cigarettes. Frontiers in Pharmacology, 7, 2016, 279.
121. Peace, M.R., Stone, J.W., Poklis, J.L., Turner, J.B., Poklis, A., Analysis of a commercial marijuana e-cigarette formulation. Journal of Analytical Toxicology 40 (2016), 374–378.
122. Peters, E.N., Budney, A.J., Carroll, K.M., Clinical correlates of co-occurring cannabis and tobacco use: A systematic review. Addiction 107 (2012), 1404–1417.
123. Peters, E.N., Schauer, G.L., Rosenberry, Z.R., Pickworth, W.B., Does marijuana blunt smoking contribute to nicotine exposure? Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking. Drug and Alcohol Dependence 168 (2016), 119–122.
124. Pierre, J.M., Gandal, M., Son, M., Cannabis-induced psychosis associated with high potency wax dabs. Schizophrenia Research 172 (2016), 211–212.
125. Pletcher, M.J., Vittinghoff, E., Kalhan, R., Richman, J., Safford, M., Sidney, S., et al. Association between marijuana exposure and pulmonary function over 20 years. Journal of the American Medical Association 307 (2012), 173–181.
126. Pomahacova, B., Van der Kooy, F., Verpoorte, R., Cannabis smoke condensate III: The cannabinoid content of vaporised Cannabis sativa. Inhalation Toxicology 21 (2009), 1108–1112.
127. Raber, J.C., Elzinga, S., Kaplan, C., Understanding dabs: Contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. The Journal of Toxicological Sciences 40 (2015), 797–803.
128. Ramo, D.E., Liu, H., Prochaska, J.J., Tobacco and marijuana use among adolescents and young adults: A systematic review of their co-use. Clinical Psychology Review 32 (2012), 105–121.
129. Ream, G.L., Johnson, B.D., Sifaneck, S.J., Dunlap, E., Distinguishing blunts users from joints users: A comparison of marijuana use subcultures. Cole, S.M., (eds.) New research on street drugs, 2006, Nova Science Publishers, Inc, Hauppauge, New York, 245–273.
130. Ream, G.L., Benoit, E., Johnson, B.D., Dunlap, E., Smoking tobacco along with marijuana increases symptoms of cannabis dependence. Drug and Alcohol Dependence 95 (2008), 199–208.
131. Romanowski, K.S., Barsun, A., Kwan, P., Teo, E.H., Palmieri, T.L., Sen, S., et al. Butane hash oil burns: A 7-Year perspective on a growing problem. Journal of Burn Care & Research 38 (2016), e-165–e-171.
132. Room, R., Legalising a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond. Addiction 109 (2014), 345–351.
133. Schauer, G.L., Berg, C.J., Kegler, M.C., Donovan, D.M., Windle, M., Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of tobacco and marijuana in adults from 2003 to 2012. Addictive Behaviors 49 (2015), 26–32.
134. Schauer, G.L., King, B.A., Bunnell, R.E., Promoff, G., McAfee, T.A., Toking, vaping, and eating for health or fun: Marijuana use patterns in adults, U.S., 2014. American Journal of Preventive Medicine 50 (2016), 1–8.
135. Schauer, G.L., Rosenberry, Z.R., Peters, E.N., Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: A systematic literature review. Addictive Behaviors 64 (2016), 200–211.
136. Schneberk, T., Sterling, G.P., Valenzuela, R., Mallon, W.K., A little dab will do ya: An emergency department case series related to a new form of high-potency marijuana known as wax. Annals of Emergency Medicine, 64, 2014, S139.
137. Schneberk, T., Valenzuela, R.G., Sterling, G., Mallon, W.K., Hot wax. JEMS: a Journal of Emergency Medical Services 40 (2015), 44–52.
138. Sexton, M., Cuttler, C., Finnell, J.S., Mischley, L.K., A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy. Cannabis and Cannabinoid Research 1 (2016), 131–138.
139. Shiplo, S., Asbridge, M., Leatherdale, S.T., Hammond, D., Medical cannabis use in Canada: Vapourization and modes of delivery. Harm Reduction Journal, 13, 2016, 30.
140. Sifaneck, S.J., Kaplan, C.D., Dunlap, E., Johnson, B.D., Blunts and blowtjes: Cannabis use practices in two cultural settings and their implications for secondary prevention. Free Inquiry in Creative Sociology 31 (2003), 3–14.
141. Sifaneck, S.J., Johnson, B.D., Dunlap, E., Cigars-for-blunts: Choice of tobacco products by blunt smokers. Journal of Ethnicity in Substance Abuse 4 (2005), 23–42.
142. Sinclair, C.F., Foushee, H.R., Pevear, I.J.S., Scarinci, I.C., Carroll, W.R., Patterns of blunt use among rural young adult African-American men. American Journal of Preventive Medicine 42 (2012), 61–64.
143. Singh, T., Kennedy, S.M., Sharapova, S.S., Schauer, G.L., Rolle, I.V., Modes of ever marijuana use among adult tobacco users and non-tobacco users—Styles 2014. Journal of Substance Use 21 (2016), 631–635.
144. Smith, D., Bloor, R., George, C., Pysanenko, A., Španěl, P., Release of toxic ammonia and volatile organic compounds by heated cannabis and their relation to tetrahydrocannabinol content. Analytical Methods 7 (2015), 4104–4110.
145. Soldz, S., Huyser, D.J., Dorsey, E., The cigar as a drug delivery device: Youth use of blunts. Addiction (Abingdon England) 98 (2003), 1379–1386.
146. Soller, B., Lee, J.P., Drug-intake methods and social identity: The use of marijuana in blunts among Southeast Asian adolescents and emerging adults. Journal of Adolescent Research 25 (2010), 783–806.
147. Stahlmann, C.G., McMahon, M., Bhatt, N.A., Perkins, M.P., Philip, A.I., Dabble with danger: A case of severe respiratory failure following inhalation of butane hash oil. American Journal of Respiratory and Critical Care Medicine, 2015, 191.
148. Stogner, J.M., Miller, B.L., Assessing the dangers of dabbing: Mere marijuana or harmful new trend?. Pediatrics 136 (2015), 1–3.
149. Stogner, J.M., Miller, B.L., The dabbing dilemma: A call for research on butane hash oil and other alternate forms of cannabis use. Substance Abuse 36 (2015), 393–395.
150. Subritzky, T., Pettigrew, S., Lenton, S., Issues in the implementation and evolution of the commercial recreational cannabis market in Colorado. International Journal of Drug Policy 27 (2016), 1–12.
151. Sullivan, N., Elzinga, S., Raber, J.C., Determination of pesticide residues in cannabis smoke. Journal of Toxicology, 2013, 2013, 378168.
152. Swift, W., Gates, P., Dillon, P., Survey of Australians using cannabis for medical purposes. Harm Reduction Journal, 2, 2005, 18.
153. Tait, R.J., Caldicott, D., Mountain, D., Hill, S.L., Lenton, S., A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology (Philadelphia Pa.) 54 (2016), 1–13.
154. Tan, W.C., Lo, C., Jong, A., Xing, L., Fitzgerald, M.J., Vollmer, W.M., et al. Marijuana and chronic obstructive lung disease: A population-based study. CMAJ: Canadian Medical Association Journal 180 (2009), 814–820.
155. Tashkin, D.P., Simmons, M.S., Tseng, C.H., Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD: Journal of Chronic Obstructive Pulmonary Disease 9 (2012), 367–374.
156. Tashkin, D.P., Increasing cannabis use: What we still need to know about its effects on the lung. Respirology 19 (2014), 619–620.
157. Tashkin, D.P., How beneficial is vaping cannabis to respiratory health compared to smoking?. Addiction (Abingdon, England) 110 (2015), 1706–1707.
158. Task Force on Cannabis Legalization and Regulation, A framework for the legalization and regulation of cannabis in Canada: The final report of the task force on cannabis legalization and regulation., 2016, Health Canada, Ottawa, ON.
159. Thu, K., Hayes, M., Miles, S., Tierney, L., Foy, A., Marijuana ‘bong' smoking and tuberculosis. Internal Medicine Journal 43 (2013), 456–458.
160. Timberlake, D.S., A comparison of drug use and dependence between blunt smokers and other cannabis users. Substance Use and Misuse 44 (2009), 401–415.
161. Timberlake, D.S., The changing demographic of blunt smokers across birth cohorts. Drug and Alcohol Dependence 130 (2013), 129–134.
162. United Nations Office on Drugs and Crime (UNODC), World drug report 2015., 2015, United Nations Office on Drugs and Crime, Vienna, Austria.
163. Van Dam, N.T., Earleywine, M., Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer. The International Journal of Drug Policy 21 (2010), 511–513.
164. van der Pol, P., Liebregts, N., Brunt, T., van Amsterdam, J., de Graaf, R., Korf, D.J., et al. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: An ecological study. Addiction (Abingdon England) 109 (2014), 1101–1109.
165. Vandrey, R., Raber, J.C., Raber, M.E., Douglass, B., Miller, C., Bonn-Miller, M.O., Cannabinoid dose and label accuracy in edible medical cannabis products. Journal of the American Medicial Association 313 (2015), 2491–2493.
166. Varlet, V., Concha-Lozano, N., Berthet, A., Plateel, G., Favrat, B., De Cesare, M., et al. Drug vaping applied to cannabis: Is Cannavaping a therapeutic alternative to marijuana?. Scientific Reports, 6, 2016, 25599.
167. Varlet, V., Drug vaping: From the dangers of misuse to new therapeutic devices. Toxics, 4, 2016, 29.
168. Volkow, N.D., Baler, R.D., Compton, W.M., Weiss, S.R.B., Adverse health effects of marijuana use. New England Journal of Medicine 370 (2014), 2219–22227.
169. Wang, G.S., Roosevelt, G., Heard, K., Pediatric marijuana exposures in a medical marijuana state. Journal of the American Medical Association: Pediatrics 167 (2013), 630–633.
170. Wang, G.S., Roosevelt, G., Le Lait, M.C., Martinez, E.M., Bucher-Bartelson, B., Bronstein, A.C., et al. Association of unintentional pediatric exposures with decriminalization of marijuana in the United States. Annals of Emergency Medicine 63 (2014), 684–689.
171. Wang, G.S., Le Lait, M.C., Deakyne, S.J., Bronstein, A.C., Bajaj, L., Roosevelt, G., Unintentional pediatric exposures to marijuana in Colorado, 2009–2015. Journal of the American Medicial Association: Pediatrics, 170, 2016, e160971.
172. Wang, G.S., Pediatric concerns due to expanded cannabis use: Unintended consequences of legalization. Journal of Medical Toxicology 13 (2017), 99–105 [Springer.].
173. Weiss, S., Edibles: For experts only? Ingesting marijuana, as opposed to smoking it, has come a long way since the days of homemade pot brownies. State Legislatures, 41, 2015, 23.
174. World Health Organization (WHO), The health and social effects of nonmedical cannabis use. 2016, World Health Organization, Geneva, Switzerland.
175. Zhang, L.R., Morgenstern, H., Greenland, S., Chang, S.C., Lazarus, P., Teare, M.D., et al. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. International Journal of Cancer 136 (2015), 894–903.
176. Zhang, Z., Zheng, X., Zeng, D.D., Leischow, S.J., Tracking dabbing using search query surveillance: A case study in the United States. Journal of Medical Internet Research, 18, 2016, e252.